Wed.Jun 19, 2024

article thumbnail

Blood test could spot Parkinson’s years earlier

pharmaphorum

An AI-powered blood test that may be able to predict Parkinson’s years before symptoms develop could allow earlier treatment and guide trials of new treatments

128
128
article thumbnail

Putting Payers in the Driver’s Seat: How the New CMS Interoperability and Prior Authorization is Changing Healthcare

MedCity News

Key questions that must be answered The post Putting Payers in the Driver’s Seat: How the New CMS Interoperability and Prior Authorization is Changing Healthcare appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Marea’s $190m double round heads latest biotech financings

pharmaphorum

Marea Therapeutics raises $190m for cardiometabolic pipeline, with Santa Ana Bio, Opthea, InduPro, Elion, and iOnctura also completing rounds

111
111
article thumbnail

Researchers design genetic mole reversal therapy for rare skin condition

PharmaTimes

Congenital melanocytic naevus syndrome can cover up to 80% of the bodies of children

107
107
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Third fire at Novo Nordisk, but company says there’s no link

pharmaphorum

Novo Nordisk has been affected by a third fire in a month, the latest involving an office building near its Copenhagen headquarters.

110
110
article thumbnail

Researchers reveal genetic makeup could identify treatment options for sepsis

PharmaTimes

The serious condition is responsible for approximately 11 million deaths worldwide every year

106
106

More Trending

article thumbnail

Sobi gets EU okay for long-acting haemophilia A drug

pharmaphorum

Sobi’s long-acting rVIII drug Altuvoct has been cleared for haemophilia A in the EU, with a label that spans all ages and any disease severity.

105
105
article thumbnail

Pharma Pulse 6/19/24: DIA 2024 Coverage, How Orange Peels Connect to Heart Health & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 104
article thumbnail

Non-chemotherapy lymphoma treatment may provide durable remission

European Pharmaceutical Review

A non-chemotherapy multi-drug therapy enabled complete remission in 38 percent of evaluable patients with aggressive B-cell lymphoma, a Phase Ib/II clinical trial shows. This was observed in individuals who had experienced a return of their cancer or who were unresponsive to standard treatments. Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) were used together in a treatment regimen in 50 patients with diffuse large B-cell lymphoma (DLBCL).

article thumbnail

Looking Ahead to Cardinal Health's Biosimilar Pipeline

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno, Fran Gregory, PharmD, Vice President of Emerging Therapies, Cardinal Health, discusses what to expect from Cardinal Health's biosimilars pipeline.

Pharma 80
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

IBI-343 by Innovent Biologics for Solid Tumor: Likelihood of Approval

Pharmaceutical Technology

IBI-343 is under clinical development by Innovent Biologics and currently in Phase I for Solid Tumor.

75
article thumbnail

Amazon extends $5 generic subscription service to Medicare

pharmaphorum

Amazon Pharmacy is expanding its subscription service for generic medicines, making it available to Medicare patients

article thumbnail

Speaking a Second Language Has Countless Benefits in the Pharmacy Setting

Pharmacy Times

Being able to communicate in a different language can improve treatment adherence and medication efficacy outcomes

Medical 68
article thumbnail

The Right Sales Training is Essential to Educating and Motivating Sales Teams

Integrity Solutions

Why are some salespeople uniquely successful? Do they have some special sales skills that others don’t? If your sales force is somewhat normal, just 20% are high performers. Imagine what a difference it would make if motivating sales teams was tied directly to sales training and increasing their ability develop stronger customer relationships and sell more.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

How AI is Transforming Insurance: Boosting Sales, Efficiency, and Customer Engagement

Quantified

Executive Summary Artificial Intelligence (AI) is revolutionizing the insurance industry, enhancing customer interactions, risk assessment, and operational efficiency. This report examines AI’s influence on underwriting, predictive analytics, customer service, regulatory compliance, certification training, and the benefits for insurance sales teams.

article thumbnail

Pharma and medtech companies need to team up for wound management

Pharmaceutical Technology

Polaroid Therapeutics’ CEO suggests that pharma should partner with medtech to prevent antibiotic resistance in wound management.

article thumbnail

Expert: Maternal Health Disparities, Role of Pharmacists in Improving Outcomes

Pharmacy Times

Reducing maternal mortality through improving access, screening, education and providing support during pregnancy.

article thumbnail

How Networking Leads To Success In Medical Device Sales With Josh Reynolds

Evolve Your Success

Unlock the secrets of simplifying complex medical procedures and fast-track your career in the competitive medical sales industry. In this enlightening episode, we sit down with Josh Reynolds, the Area Vice President of Sales in the Southeast for OrthoFundamentals, to explore the innovative landscape of SI joint fusion. Discover how OrthoFundamentals is redefining industry standards with their streamlined processes and cutting-edge products.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Educate Patients About Cough and Cold Product Ingredients

Pharmacy Times

Read the Drug Facts Label to Learn More About OTC Medications.

article thumbnail

FDA Approves AbbVie’s Skyrizi for the Treatment of Adults with Moderate to Severely Active Ulcerative Colitis

PharmExec

Approval of Skyrizi marks the first IL-23 specific inhibitor approved for both ulcerative colitis and Crohn disease of similar severity, according to AbbVie.

FDA 52
article thumbnail

EMA Reviews Risks of CAR T-Cell Medicines and Painkillers

PharmaTech

PRAC is reviewing the risk of secondary malignancies in patients treated with CAR T-cell medicines.

article thumbnail

Ascidian Therapeutics, Roche Enter RNA Exon Editing Therapeutics Collaboration

Pharmaceutical Commerce

Deal will target neurological diseases, featuring an initial payment of $42 million for Ascidian and up to $1.8 billion in milestone payments/royalties.

52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors

PharmExec

In an interview with Pharm Exec Associate Editor Don Tracy, Pedro Valencia, VP, Solid Tumor Pipeline Strategy & Execution, AbbVie, discusses using novel cancer biomarkers to develop potential first-in-class antibody drug conjugates (ADCs) and the promise that they offer.

52
article thumbnail

How Clinical Sites Can Master Signal-Based Prospecting to Secure Their Next Big Trial

Zymewire

Master signal-based prospecting to secure your next big clinical trial.

article thumbnail

Sapiens Announces AI-Powered Insurance Platform

PharmExec

The platform will use machine-learning and generative AI to provide insurers with a variety of options and increase automation in their processes.

article thumbnail

Marea launches with $190m to develop cardiometabolic therapies

Pharmaceutical Technology

Marea Therapeutics has launched with funding of $190m in a bid to develop cardiometabolic disease treatments.

52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

The Potential of CAR T Therapies: Q&A with Ying Huang

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Unither invests $106m in Monroe County NY facility modernisation

Pharmaceutical Technology

Unither Pharmaceuticals has announced a $106m investment to upgrade its Monroe County facility in New York, US.

article thumbnail

Pharma Pulse 6/19/24: How AI is Revolutionizing Drug Development, Coverage from DIA 2024 & more

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52
article thumbnail

AbbVie’s SKYRIZI gains US FDA approval for ulcerative colitis

Pharmaceutical Technology

AbbVie has received FDA approval for SKYRIZI to treat adult patients with moderately to severely active ulcerative colitis.

FDA 52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A